What Is The Best Time Sampling For The Two Direct Oral Anticoagulants, Dabigatran and Rivaroxaban?

被引：0
|
作者：
Douxfils, Jonathan
Classen, Jean-Francois
Baudar, Justine
Devalet, Berangere
Samama, Meyer Michel
Chatelain, Bernard
Dogne, Jean-Michel
Mullier, Francois
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4805
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay
    Artang, Ramin
    Anderson, Maren
    Riley, Paul
    Nielsen, Jorn D.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2017, 1 (02) : 194 - 201
  • [22] Emergency surgery and trauma in patients treated with the new oral anticoagulants: Dabigatran, rivaroxaban, and apixaban
    Moorman, Matthew L.
    Nash, Joshua E.
    Stabi, Katie L.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 (03): : 486 - 494
  • [23] What Oral Anticoagulant Is Best After TAVR Vitamin K Antagonists or Direct Oral Anticoagulants?
    Berg, Jurrien M. ten
    Overduin, Daniel C.
    van Ginkel, Dirk-Jan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (03) : 419 - 421
  • [24] Management of dental patients taking direct oral anticoagulants: Dabigatran
    Hassona, Y.
    Malamos, D.
    Shaqman, M.
    Baqain, Z.
    Scully, C.
    ORAL DISEASES, 2018, 24 (1-2) : 228 - 232
  • [25] Prevalence of Intracardiac Thrombi Under Phenprocoumon, Direct Oral Anticoagulants (Dabigatran and Rivaroxaban), and Bridging Therapy in Patients With Atrial Fibrillation and Flutter
    Zylla, Maura M.
    Pohlmeier, Mara
    Hess, Alexander
    Mereles, Derliz
    Kieser, Meinhard
    Bruckner, Thomas
    Scholz, Eberhard
    Zitron, Edgar
    Schweizer, Patrick A.
    Katus, Hugo A.
    Thomas, Dierk
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (05): : 635 - 640
  • [26] SYSTEMATIC ASSESSMENT OF THE EFFECT OF DIRECT ORAL ANTICOAGULANTS DABIGATRAN, RIVAROXABAN AND APIXABAN USING CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY IN VIVO
    Artang, Ramin
    Anderson, Maren
    Riley, Paul
    Nielsen, Joern Dalsgaard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 768 - 768
  • [27] What is the monitoring for oral direct anticoagulants?
    Vaillant-Roussel, Helene
    Cadwallader, Jean-Sebastien
    Gelly, Julien
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2015, 26 (121): : 240 - 240
  • [28] AN AUDIT TO DETERMINE THE SAFETY OF THE NOVEL ORAL ANTICOAGULANTS, DABIGATRAN AND RIVAROXABAN, FOR PATIENTS INITIATED ON ANTICOAGULANT THERAPY
    Kurunadalingam, H.
    Vizcaychipi, M. P.
    Patel, S.
    Gabriel, I. H.
    Yarranton, H.
    Morgan, D. J. Richard
    ANESTHESIA AND ANALGESIA, 2014, 118 : S216 - S216
  • [29] Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development
    Ufer, Mike
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (03) : 572 - 585
  • [30] AN AUDIT TO DETERMINE THE SAFETY OF THE NOVEL ORAL ANTICOAGULANTS, DABIGATRAN AND RIVAROXABAN, FOR PATIENTS INITIATED ON ANTICOAGULANT THERAPY
    Kurunadalingam, H.
    Patel, S.
    Gabriel, I.
    Morgan, R.
    Yarranton, H.
    Vizcaychipi, M.
    HAEMATOLOGICA, 2014, 99 : 212 - 213
12345